Optiflow is at the forefront of its field, featuring in hundreds of publications in journals such as NEJM and JAMA.
Used as a first-line treatment across the care continuum, Optiflow may reduce patient escalation resulting in better clinical outcomes.
Hundreds of randomized controlled trials have been consolidated into clinical practice guidelines. These guidelines underscore the breadth of application of nasal high flow therapy.
We’ve created a table that will help you review the guidelines by patient population and application.
Explore our regularly updated, frequently asked questions about: 1. implementing Optiflow high-flow therapy. 2. the science of high-flow therapy, including the mechanisms of action and patient outcomes.
Hundreds of publications per year are being consolidated into practice guidelines and revealing insights into new applications. Flow Matters keeps you up-to-date with this ever-evolving field of research.
or get in touch by email, using the form below
Find clinical evidence and practice guidelines for delivering nasal high flow (aka HFNC) therapy.
Featuring under nose NIV masks (F&P Visairo) and full face NIV masks - (F&P Nivairo), with vented and non-vented options to suit your hospital NIV mask needs.
Providing Optimal Humidity for intubated patients
Establish effective spontaneous breathing or assist ventilation of the lungs
Respiratory support that replaces spontaneous breathing
Noninvasive respiratory support that provides a continuous distending pressure
Noninvasive respiratory support that delivers high flows of blended air and oxygen
Designed to work in harmony with the way patients naturally breathe while they sleep
F&P SleepStyle - designed to strike the balance between comfort and effective treatment
This access is intended for health professionals only and by accessing it you agree to be a health professional. I am a health professional.
Remember my choice